

GVP5+8Q5, Phnom Penh, Cambodia
NEO-K Tab. 5 mg / 50 mg / 17.5 mg / 1.5 mg
Prescription notice
Item may require a valid prescription. Please consult your doctor or pharmacist before using new medication.
Last updated 28/08/2026 at 5:12 PM

GVP5+8Q5, Phnom Penh, Cambodia
Indication
Used for cough and sputum.
Ingredients
- Dihydrocodeine bitartrate 5 mg
- Guaifenesin 50 mg
- DL
- Methylephedrine HCl 17.5 mg
- Chlorpheniramine maleate 1.5 mg
Direction
Adults: 2 tablets orally 3 times a day. Children 8 to 11 years of age: 1 tablet orally 3 times a day. Children 11 to 15 years of age: 1 to 2 tablets orally 3 times a day. For more details, refer to the enclosed circular.
Side effects
- Drowsiness
- sedation.
- Nausea
- vomiting
- constipation.
- Dry mouth
- blurred vision.
- Urinary retention.
- Palpitations
- tachycardia.
- Dizziness
- headache.
- Nervousness or excitability (especially in children).
- Skin rash or allergic reactions.
- Respiratory depression at high doses.
Precautions
- Do not use in children under 12 years old.
- Contraindicated in patients with severe respiratory depression
- acute asthma
- or chronic obstructive pulmonary disease (COPD).
- Contraindicated in patients with hypersensitivity to any component
- including codeine
- type opioids.
- Use with caution in patients with hypertension
- cardiovascular disease
- hyperthyroidism
- diabetes mellitus
- or enlarged prostate.
- Do not use concurrently with MAO inhibitors or within 14 days of stopping them.
- Use with caution with CNS depressants
- alcohol
- sedatives
- or tricyclic antidepressants
- additive effects may occur.
- Dihydrocodeine is an opioid
- risk of dependence
- misuse
- and overdose with prolonged use.
- Chlorpheniramine may cause drowsiness
- avoid driving or operating heavy machinery.
- Not recommended during pregnancy or breastfeeding without medical advice.
- Keep out of reach of children.
Indication
Used for cough and sputum.
Ingredients
- Dihydrocodeine bitartrate 5 mg
- Guaifenesin 50 mg
- DL
- Methylephedrine HCl 17.5 mg
- Chlorpheniramine maleate 1.5 mg
Direction
Adults: 2 tablets orally 3 times a day. Children 8 to 11 years of age: 1 tablet orally 3 times a day. Children 11 to 15 years of age: 1 to 2 tablets orally 3 times a day. For more details, refer to the enclosed circular.
Side effects
- Drowsiness
- sedation.
- Nausea
- vomiting
- constipation.
- Dry mouth
- blurred vision.
- Urinary retention.
- Palpitations
- tachycardia.
- Dizziness
- headache.
- Nervousness or excitability (especially in children).
- Skin rash or allergic reactions.
- Respiratory depression at high doses.
Precautions
- Do not use in children under 12 years old.
- Contraindicated in patients with severe respiratory depression
- acute asthma
- or chronic obstructive pulmonary disease (COPD).
- Contraindicated in patients with hypersensitivity to any component
- including codeine
- type opioids.
- Use with caution in patients with hypertension
- cardiovascular disease
- hyperthyroidism
- diabetes mellitus
- or enlarged prostate.
- Do not use concurrently with MAO inhibitors or within 14 days of stopping them.
- Use with caution with CNS depressants
- alcohol
- sedatives
- or tricyclic antidepressants
- additive effects may occur.
- Dihydrocodeine is an opioid
- risk of dependence
- misuse
- and overdose with prolonged use.
- Chlorpheniramine may cause drowsiness
- avoid driving or operating heavy machinery.
- Not recommended during pregnancy or breastfeeding without medical advice.
- Keep out of reach of children.
You may also like
Similar medicines from ឱសថស្ថាន ត្រពាំងថ្លឹង



